How is HIV/AIDS Diagnosed?

A person with suspected HIV infection should undergo recommended HIV testing through an HIV testing centre or a qualified doctor. After HIV is confirmed, treatment planning usually includes a viral load test, CD4 count and kidney and liver function tests. Screening for tuberculosis, hepatitis B, hepatitis C and other infections may also be required. Resistance testing may be considered when treatment failure is suspected.

How is HIV/AIDS Treated Based on Severity?

HIV is not treated according to simple mild, moderate and severe symptom categories. Treatment decisions are based on viral load, immune function, clinical condition, opportunistic infections, previous ART and possible drug resistance.

Treatment becomes more complex when immunity is severely reduced or complications are present. The table below summarises treatment for HIV/AIDS according to the person's clinical status:

Clinical Situation Typical Treatment Approach
HIV without advanced disease Start ART promptly after diagnosis and clinical assessment, followed by regular viral load monitoring and adherence support.
Symptomatic or advanced HIV ART together with screening, prevention and treatment of opportunistic infections and other HIV-related complications.
HIV with a serious opportunistic infection Treat the infection and start or continue ART at an appropriate time; certain infections may require carefully planned ART timing.
Virological failure or suspected drug resistance Assess adherence, medicine interactions and resistance, then modify the ART regimen when necessary.

Types of HIV and Their Treatment

The two main types of HIV respond differently to some antiretroviral medicine classes. Correct identification can therefore affect treatment selection.

The table below summarises the treatment approach for HIV-1 and HIV-2:

Type Treatment Approach
HIV-1 Combination ART is used, commonly with an integrase inhibitor such as dolutegravir together with two suitable nucleoside/nucleotide reverse transcriptase inhibitors.
HIV-2 Combination ART is also required, but treatment should generally use an integrase inhibitor-based or other active regimen because HIV-2 is naturally resistant to non-nucleoside reverse transcriptase inhibitors.

Stages of HIV/AIDS and Their Treatment

ART is recommended throughout HIV infection rather than being reserved for a particular stage. The main difference between stages is the amount of additional treatment and monitoring required for complications.

The table below summarises treatment priorities across the main clinical phases of HIV infection:

Clinical Phase Treatment Approach
Acute HIV infection Start ART promptly after confirmation and clinical assessment.
Chronic HIV without advanced disease Continue lifelong ART with viral load monitoring, preventive care and management of other health conditions.
Advanced HIV disease ART plus intensive screening, prevention and treatment of opportunistic infections and closer clinical follow-up.
AIDS-defining illness ART together with specific treatment for the associated infection, cancer or other complication, with ART timing adjusted when clinically necessary.

Other Treatments for HIV/AIDS

Other treatments for HIV/AIDS are given below:

  1. Long-Acting Injectable ART Long-acting cabotegravir with rilpivirine can replace daily oral ART in selected people with HIV-1 who have achieved viral suppression and have no relevant resistance or other contraindications. Injections are given at scheduled intervals and are not the usual starting treatment for newly diagnosed HIV.

  2. Treatment of Opportunistic Infections People with weakened immunity may require specific antimicrobial treatment for infections such as tuberculosis, cryptococcal disease, severe bacterial infections or other opportunistic infections.

  3. Prevention of Opportunistic Infections Preventive medicines may be prescribed when a low CD4 count or other clinical factors increase the risk of certain infections. As the immune system recovers with effective ART, the need for these medicines can be reassessed.

  4. Tuberculosis Preventive Treatment People with HIV who are eligible for tuberculosis preventive treatment may receive a short-course or other recommended preventive regimen after active tuberculosis has been excluded.

  5. Treatment of HIV-Associated Cancers Cancers associated with advanced HIV require cancer-specific treatment alongside effective ART, with attention to medication interactions and immune status.

  6. Treatment During Pregnancy ART should be started or continued during pregnancy to protect the mother's health and maintain viral suppression. The treatment plan, delivery management and medicines given to the baby after birth are selected according to the mother's viral load, ART history and clinical situation.

Oral Medications for HIV/AIDS

HIV treatment uses combinations of antiretroviral medicines rather than a single drug. The exact regimen depends on previous treatment, resistance, kidney and liver function, pregnancy, hepatitis co-infection and medicine interactions.

Some common oral medications for HIV/AIDS treatment are:

  • Dolutegravir-based Combinations: Dolutegravir is commonly combined with tenofovir and lamivudine as a first-line treatment option.

  • Tenofovir Disoproxil Fumarate (TDF): Commonly used as part of combination ART with lamivudine or emtricitabine and another active medicine.

  • Tenofovir Alafenamide (TAF): Another form of tenofovir used in selected combination regimens.

  • Lamivudine (3TC) or Emtricitabine (FTC): Common backbone medicines used with other active antiretrovirals.

  • Bictegravir-based Combinations: May be used as a single tablet combination ART in suitable patients where available.

  • Boosted Darunavir-based Treatment: May be useful in selected people with previous treatment failure or drug-resistant HIV.

  • Other Antiretroviral Classes: Additional medicines may be selected when resistance, intolerance or medicine interactions limit standard regimens.

ART should not be changed, interrupted or stopped without medical advice.

Ayurvedic and Alternative Treatments for HIV/AIDS

Ayurvedic, herbal and other alternative therapies cannot cure HIV or replace ART. The following therapies can complement, and not replace, evidence-based medicines for HIV/AIDS:

  • Ayurvedic medicines should not replace prescribed antiretroviral treatment.

  • Herbal products should be discussed with the treating doctor because some can interact with ART.

  • Yoga, meditation and relaxation techniques may support stress management.

  • Nutritional supplements do not suppress HIV and should be used only when appropriate.

Home Care for Managing HIV/AIDS

Home care mainly supports treatment adherence, general health and early recognition of complications. Some home care measures to manage HIV/AIDS are given below:

  • Take ART at the prescribed time and avoid missed doses.

  • Attend scheduled viral load tests and clinical reviews.

  • Complete treatment prescribed for opportunistic infections.

  • Maintain adequate nutrition and hydration.

  • Follow recommended vaccination and preventive-care advice.

  • Check new medicines or supplements for possible interactions with ART.

  • Seek medical advice for persistent fever, unexplained weight loss, breathing difficulty, prolonged diarrhoea or other new symptoms.

  • Keep an adequate supply of ART, including when travelling.

How Long Does Treatment for HIV/AIDS Take?

HIV treatment is generally lifelong because current ART suppresses the virus but does not eliminate it from the body. Treatment for HIV-related infections or complications may last from days to several months.

Duration, therefore, depends on the treatment being used and the clinical situation. The table below summarises approximate durations for various treatments of HIV/AIDS:

Treatment Approximate Duration
Antiretroviral therapy Lifelong, with regular monitoring and treatment review.
Bacterial opportunistic-infection treatment Usually days to several weeks, depending on the infection.
Tuberculosis treatment Usually several months, depending on the type of tuberculosis and regimen used.
Cryptococcal meningitis treatment Initial intensive therapy followed by consolidation and maintenance treatment over several months.
Preventive treatment for selected opportunistic infections Continued according to immune status and the specific infection risk.
Long-acting injectable ART Repeated injections at the prescribed interval for as long as the regimen remains suitable and effective.

Viral load testing is used to assess whether ART is successfully suppressing HIV, while CD4 testing may be especially important in people with advanced disease or selected clinical concerns.

HIV/AIDS Treatment Side Effects

Side effects of HIV/AIDS treatment vary according to the medicines used. Many people tolerate modern ART well. Nonetheless, possible side effects of HIV/AIDS treatment include:

  • Nausea or vomiting

  • Diarrhoea

  • Headache

  • Fatigue

  • Dizziness

  • Disrupted sleep patterns

  • Rash on the skin

  • Weight and appetite changes

  • Alterations in kidney or liver functioning when taking some drugs

  • Metabolic and cardiovascular impacts of certain drugs

Persistent or severe side effects should be reported to the treating doctor because the treatment regimen can often be adjusted rather than stopped.

Lifestyle Changes for Managing HIV/AIDS

Lifestyle measures support general health but do not replace ART. Some lifestyle measures to manage HIV/AIDS are given below:

  • Take ART consistently.

  • Eat a balanced diet and exercise according to health and fitness.

  • Avoid smoking and tobacco.

  • Limit excessive alcohol intake.

  • Get adequate sleep.

  • Keep recommended vaccinations and preventive care up to date.

  • Manage other long-term health conditions.

  • Attend regular medical and viral load follow-up.

  • Seek support for mental health or treatment-adherence difficulties when needed.

Maintaining an undetectable viral load through effective ART prevents sexual transmission of HIV while viral suppression is sustained.

Triggers That Can Worsen HIV/AIDS Symptoms

HIV does not have typical symptom triggers in the same way as conditions such as asthma or migraine. However, certain factors can reduce treatment effectiveness, weaken immune control or increase the risk of HIV-related illness. These triggers are listed below:

  • Missing ART doses repeatedly or stopping ART

  • Drug interactions that reduce antiretroviral levels

  • Development of drug resistance

  • Untreated opportunistic infections

  • Poor nutrition or significant weight loss

  • Heavy alcohol or substance use that interferes with treatment adherence

  • Smoking

  • Delayed medical assessment when new symptoms develop

Treatment Cost for HIV/AIDS

HIV/AIDS treatment costs in India vary according to whether care is obtained through public or private hospitals, the ART regimen, laboratory monitoring and treatment of complications. Antiretroviral medicines and several HIV-care services are available without charge through public-sector ART centres for eligible patients. Private care may involve additional costs for doctor consultations, medicines, viral load testing and other investigations.

Treatment costs can increase substantially when advanced HIV requires hospitalisation or management of opportunistic infections.

Does Health Insurance Cover Treatment of HIV/AIDS in India?

Yes. Health insurance provides coverage for HIV-related care. Hospitalisation and treatment of HIV-related complications may be covered up to the policy's sum insured. Health insurance for HIV patients may also cover day care procedures, second medical, ambulance charges and pre & post-hospitalisation expenses. Routine ART, outpatient consultations and viral load tests will be covered with outpatient or specific HIV benefits.

Waiting periods of 30 days or 90 days may apply, depending on the policy. Hence, policy wording should be reviewed carefully before a claim is filed.

Frequently Asked Questions (FAQs)

  • Q1. Can HIV/AIDS be cured permanently?

    Ans: No. HIV/AIDS cannot be cured completely. However, continued antiretroviral therapy (ART) can help manage the spread of the virus, protect the immune system and reduce the risk of further complications.
  • Q2. What is the best treatment for HIV/AIDS?

    Ans: Combination antiretroviral therapy is the standard treatment for HIV/AIDS. The most suitable regimen depends on previous treatment, resistance, other health conditions and possible medication interactions.
  • Q3. Is ART required for life?

    Ans: Yes. ART is generally continued lifelong because HIV begins to multiply again when effective treatment is stopped.
  • Q4. Can HIV treatment make the viral load undetectable?

    Ans: Yes. Effective ART can reduce HIV to an undetectable level in many people. Maintaining an undetectable viral load also prevents sexual transmission of HIV.
  • Q5. Can a person with AIDS recover after starting ART?

    Ans: ART can allow the immune system to recover and substantially reduce HIV-related illness. People with advanced HIV may also need treatment for opportunistic infections and other complications.
  • Q6. How quickly should ART be started after an HIV diagnosis?

    Ans: ART should usually begin as soon as HIV is confirmed and the person is clinically assessed. Certain serious opportunistic infections may require the timing of ART to be adjusted.
  • Q7. What happens if HIV treatment is stopped?

    Ans: If HIV treatment is stopped, the virus can start multiplying again, which can lead to an increase in the viral load, thereby weakening the immune system. This can raise the risks of HIV-related complications and may contribute to drug resistance in some cases.
  • Q8. Is HIV treatment available free of cost in India?

    Ans: Yes. Antiretroviral medicines are available without charge through public-sector ART centres in India, although the availability of individual services or medicines may vary.
  • References

    • https://irdai.gov.in/health-dept

    • https://www.cdc.gov/global-hiv-tb/media/pdfs/2024/06/U-U-Resource-Guide-July-2024_Final.pdf

    • https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-combination-regimens

Other Disease Treatment Pages